×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

At Home Cancer Testing Market

ID: MRFR/HC/35101-HCR
100 Pages
Rahul Gotadki
October 2025

Informe de investigación de mercado de Pruebas de cáncer en el hogar por tipo de prueba (pruebas genéticas, pruebas de biomarcadores, pruebas inmunológicas, pruebas de ADN libre de células), por tipo de muestra (muestra de sangre, muestra de saliva, muestra de orina, muestra de tejido), por canal de distribución (farmacias en línea, farmacias minoristas, directo al consumidor), por usuario final (individuos, profesionales de la salud, instituciones de investigación) y por región (América del Norte, Europa, América del Sur, Asia Pacífico, Med... leer más

Compartir
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

At Home Cancer Testing Market Infographic
Purchase Options

At Home Cancer Testing Market Resumen

Las empresas clave en el mercado At Home Cancer Testing Market incluyen

Alcance del informe

Deja un comentario

FAQs

What is the current valuation of the At-Home Cancer Testing Market?

The At-Home Cancer Testing Market was valued at 3.74 USD Billion in 2024.

What is the projected market size for the At-Home Cancer Testing Market by 2035?

The market is projected to reach 19.91 USD Billion by 2035.

What is the expected CAGR for the At-Home Cancer Testing Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 16.42%.

Which companies are considered key players in the At-Home Cancer Testing Market?

Key players include Exact Sciences, GRAIL, Guardant Health, Foundation Medicine, Caris Life Sciences, OncoOne, Biocept, and NantHealth.

What are the main types of testing in the At-Home Cancer Testing Market?

The main types of testing include Genetic Testing, Biomarker Testing, Immunological Testing, and Cell-free DNA Testing.

How does the market segment by sample type?

The market segments by sample type include Blood Sample, Saliva Sample, Urine Sample, and Tissue Sample.

What distribution channels are utilized in the At-Home Cancer Testing Market?

Distribution channels include Online Pharmacies, Retail Pharmacies, and Direct-to-Consumer sales.

Who are the primary end users of At-Home Cancer Testing products?

Primary end users consist of Individuals, Healthcare Professionals, and Research Institutions.

What was the market valuation for Genetic Testing in 2024?

In 2024, the market valuation for Genetic Testing was 0.74 USD Billion.

What is the projected valuation for Biomarker Testing by 2035?

Biomarker Testing is projected to reach 5.83 USD Billion by 2035.

Descargar muestra gratis

Complete el formulario a continuación para recibir una muestra gratuita de este informe

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions